DK1026237T3 - Anvendelse af en inhibitor af Tau/neurofilament-proteinkinase PK40 - Google Patents

Anvendelse af en inhibitor af Tau/neurofilament-proteinkinase PK40

Info

Publication number
DK1026237T3
DK1026237T3 DK00104460T DK00104460T DK1026237T3 DK 1026237 T3 DK1026237 T3 DK 1026237T3 DK 00104460 T DK00104460 T DK 00104460T DK 00104460 T DK00104460 T DK 00104460T DK 1026237 T3 DK1026237 T3 DK 1026237T3
Authority
DK
Denmark
Prior art keywords
kinases
tau
inhibitor
protein kinase
neurofilament protein
Prior art date
Application number
DK00104460T
Other languages
Danish (da)
English (en)
Inventor
Vernon M Ingram
Hanno M Roder
Original Assignee
Massachusetts Inst Technology
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Massachusetts Inst Technology filed Critical Massachusetts Inst Technology
Application granted granted Critical
Publication of DK1026237T3 publication Critical patent/DK1026237T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/40—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/10011—Adenoviridae
    • C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
    • C12N2710/10341—Use of virus, viral particle or viral elements as a vector
    • C12N2710/10343—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/10011—Adenoviridae
    • C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
    • C12N2710/10341—Use of virus, viral particle or viral elements as a vector
    • C12N2710/10345—Special targeting system for viral vectors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Neurosurgery (AREA)
  • Molecular Biology (AREA)
  • Neurology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Plant Pathology (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Physics & Mathematics (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Cosmetics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK00104460T 1991-08-09 1992-07-10 Anvendelse af en inhibitor af Tau/neurofilament-proteinkinase PK40 DK1026237T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US74288091A 1991-08-09 1991-08-09
EP92915162A EP0667898B1 (en) 1991-08-09 1992-07-10 Uses of the tau/neurofilament protein kinase pk40

Publications (1)

Publication Number Publication Date
DK1026237T3 true DK1026237T3 (da) 2004-07-19

Family

ID=24986618

Family Applications (2)

Application Number Title Priority Date Filing Date
DK00104460T DK1026237T3 (da) 1991-08-09 1992-07-10 Anvendelse af en inhibitor af Tau/neurofilament-proteinkinase PK40
DK92915162T DK0667898T3 (da) 1991-08-09 1992-07-10 Anvendelser af TAU/neurofilamentproteinkinasen PK40

Family Applications After (1)

Application Number Title Priority Date Filing Date
DK92915162T DK0667898T3 (da) 1991-08-09 1992-07-10 Anvendelser af TAU/neurofilamentproteinkinasen PK40

Country Status (9)

Country Link
EP (2) EP1026237B1 (ja)
JP (1) JPH06510427A (ja)
AT (2) ATE262584T1 (ja)
AU (1) AU675410B2 (ja)
CA (1) CA2115151C (ja)
DE (2) DE69233330T2 (ja)
DK (2) DK1026237T3 (ja)
ES (2) ES2216745T3 (ja)
WO (1) WO1993003148A2 (ja)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6200768B1 (en) * 1991-12-06 2001-03-13 Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften Method of screening for compounds that dissolve paired helical filaments
US7408027B1 (en) 1991-12-06 2008-08-05 Max-Planck-Gesellschaft Zur Forderung Der Wissenchaften Tools for the diagnosis and treatment of Alzheimer's disease
CA2135471A1 (en) * 1992-05-11 1993-11-25 Steven A. Stacker Receptor-type tyrosine kinase-like molecules
US6013646A (en) * 1998-07-02 2000-01-11 Bayer Corporation Indolocarbazole derivatives useful for the treatment of neurodegenerative diseases and cancer
EP1299591A2 (en) * 2000-07-07 2003-04-09 Milliken & Company Textile substrates having durable water repellency and soil release and method for producing same
JP5186212B2 (ja) 2004-09-23 2013-04-17 ウィスタ ラボラトリーズ リミテッド メチルチオニニウム塩化物（ｍｔｃ）などのジアミノフェノチアジニウム化合物を化学合成および精製する方法
CN104080806B (zh) * 2011-10-07 2018-01-19 Ac免疫有限公司 识别Tau的磷酸化特异抗体

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR920703068A (ko) * 1989-09-15 1992-12-17 폴 레이킨드 신경변성 질환의 치료방법
HUT61567A (en) * 1990-12-07 1993-01-28 Sandoz Ag Process for producing new pharmaceutical compositions comprising 2'-o-alkyladenosine derivatives and for producing 6-cyclohexyl-2'-o-methyladenosinehydrate
WO1993003177A1 (en) * 1991-08-09 1993-02-18 Massachusetts Institute Of Technology Novel tau/neurofilament protein kinases
EP0544942A1 (en) * 1991-12-06 1993-06-09 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Novel tools for the diagnosis and treatment of Alzheimer disease

Also Published As

Publication number Publication date
ES2165358T3 (es) 2002-03-16
EP1026237B1 (en) 2004-03-24
JPH06510427A (ja) 1994-11-24
EP1026237A3 (en) 2001-03-28
ATE206755T1 (de) 2001-10-15
DK0667898T3 (da) 2002-02-04
DE69233330T2 (de) 2005-03-10
AU675410B2 (en) 1997-02-06
ATE262584T1 (de) 2004-04-15
ES2216745T3 (es) 2004-11-01
EP0667898B1 (en) 2001-10-10
DE69232121T2 (de) 2002-06-20
DE69232121D1 (de) 2001-11-15
WO1993003148A2 (en) 1993-02-18
CA2115151C (en) 2005-05-17
CA2115151A1 (en) 1993-02-18
EP1026237A2 (en) 2000-08-09
DE69233330D1 (de) 2004-04-29
EP0667898A1 (en) 1995-08-23
WO1993003148A3 (en) 1993-04-01
AU2324092A (en) 1993-03-02

Similar Documents

Publication Publication Date Title
DE69534300D1 (de) Neues multimerisierendes reagenz
EA199700061A1 (ru) Способ получения силденафила
ATE88502T1 (de) Interleukin-1-inhibitoren.
DE69731285D1 (de) Langwellig fluorezierende proteine
PT100300B (pt) Derivados de aminas heterociclicas-ciclicas, nomeadamente derivados de benzisoxazole-piperidina
DE59310337D1 (de) 2,4-Dioxo-imidazolidin-Derivate
DK0788356T3 (da) Fremgangsmåde og præparater til hæmning af proteinkinaser
DK0619806T3 (da) Fremstilling af substituerede piperidiner
FI952198A (fi) Stabiili kiteinen (6S)- ja (6R)-tetrahydrofoolihappo
PT83535B (pt) Processo para a preparacao de composicoes farmaceuticas contendo derivados de aminoacidos
DK1026237T3 (da) Anvendelse af en inhibitor af Tau/neurofilament-proteinkinase PK40
DK0638068T3 (da) Fremgangsmåde til fremstilling af (S)-3-amino-1-substitueret-pyrrolidiner
AR022150A1 (es) Acidos nucleicos derivados de monocitos y composiciones y metodos relacionados
DE69625910D1 (de) Penamsulfone als beta-laktamase inhibitoren
DK192890A (da) 24r-scumnol, fremgangsmaade til fremstilling heraf samt anvendelse af samme
NO305556B1 (no) Tiokarbamoylforbindelser og anvendelse derav samt middel for beskyttelse av tekniske materialer
TR199701011A2 (xx) 1-karba-(detia)-sefalosforin t�revleri.
DK0689440T3 (da) Anvendelse af triazinforbindelser som anxiolytikum
GR1001386B (el) Ετεροκυκλικές ενώσεις.
DK499686A (da) Heterocykliske forbindelser, fremgangsmaade til fremstilling af samme samt anvendelse af disse forbindelser
ATE38670T1 (de) Durch stickstoffhaltige heterocyclische ringe substituierte triazolo(4,3-c>pyrimidine und triazolo(1,5-c>pyrimidine.
IT8934058V0 (it) Insieme ammortizzato per bicicletta (kit).
ITTS920016V0 (it) Occhiali di prova per lenti progressive o multifocali.
SE9302990D0 (sv) Anordning vid markberedning
DK319189D0 (da) Fremgangsmaade til nedbrydning af uklarhedsdannende vinproteiner